Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dexamfetaminum
Dexamfetamine
Dextroamphetamine saccharate
Dexanfetamina
Dextroamphetamine adipate
Dexamfetamina
(+)-α-methylphenethylamine
d-amphetamine
(S)-α-methylbenzeneethanamine
Desamfetamina
(+)-α-methylphenylethylamine
(+)-(S)-amphetamine
(αS)-α-methylbenzeneethanamine
(S)-amphetamine
Dextroamphetamine
(S)-(+)-amphetamine
Dextroamphetamine sulfate
(S)-1-phenyl-2-propylamine
Dexamphetamine
(+)-amphetamine
(S)-(+)-β-phenylisopropylamine
(S)-1-phenyl-2-aminopropane
Brand Names
Mixed Salts of a Single Entity Amphetamine Product XR
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
